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Lack of Effect of Drinking Water Chlorine
on Lipid and Thyroid Metabolism in
Healthy Humans
by Robert G. Wones,'Colleen C. Deck,2 Betsy
Stadler,3 Suzanne Roark,3 Elizabeth Hogg,3 and
Lawrence A. Frohman'
Animal studiesandasinglehumanepideidological studyhavesuggestedthatchlorineindrinkingwatermay raisethe
levelofbloodcholesterol. Thepurposeofthisstudywastodetenrinewhethera4-weekexposuretodrinkingwaterchlorine
(1.5Lperday)ataconcentrationof20ppm(ppn = mg/L) undercontrolledconditionswouldaltercirculatingparameters
oflipidmetabolism inhealthyhumans. Thirtymenandthirty womeneachcompletedan8-weekprotocol duringwhich
diet (600mgcholesterol perday, 40% caloriesasfat) andotherfactorsknowntoaffectlipidmetabolism werecontrolled.
Forthe first4weeksoftheprotocol, all subjectsconsumied distilled water. Forthesecond4weeks, halfofthesubjectswere
assigned randomly todrinkl L5Lperdayofdclorinated water(20ppm), whiletheotherscontinuedddnkingdistilledwater.
Fourbloodsampleswerecollected fromeachsubjectattheendofeach4-weekstudyperiod.Comparedtothecontrolgroup,
thosesubjectsgivenchlorineshowed nosignificantchangesintotal plasmacholesterol, triglycerides, HDL-cholesterol,
LDL-cholesterol, orapolipoproteins Al, A2, orB. There wasatrendtowardlowserumthyroxine andtriiodothyronine
levelsinmengiwnchlorine, thoughthyroid-smulatinghormonelevelswereun d.Thistrend,ifreal,wasnotclinical-
lysignificant. Thus, short-termexposuretochlorinateddrinkingwaterat20ppmappearstohavenosignificantimpact
on parametersoflipid orthyroid metabolism in healthy humans.
Introduction
Exposure ofhumans to chlorinated drinking water disinfec-
tants is almost universal intheUnitedStates (1). Chlorine isused
by the vast majority ofpublic water systems thatdisinfect their
water. Even persons whoconsume waterfromuntreated sources
may beexposed tochlorine infoods (2,3) orinswimmingpools.
Revis and colleagues have studied theeffectofdrinking water
chlorine on lipid metabolism and thyroid function in white
Carneau pigeons (4). Pigeons consuming a high-fat, high-
cholesterol, low-calcium dietexperienced a significant increase
in serum cholesterol and a decrease in serum thyroxine when
givenchlorinated watertodrink. Theseeffects wereobserved at
low concentrations ofdrinking waterchlorine inthe range con-
sumed by humans.
Investigations of the effects of chlorine on human lipid and
thyroid metabolism are limited. Lubbers andcolleaguesexposed
healthy human volunteers to low and nigh concentrations of
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chlorine and other chlorinated disinfectants for briefintervals
andobservednoeffectontotalcholesterol levels (5). Morepro-
longed exposure to5 ppmchlorinealsohad no apparent effect.
However, dietandtheintakeofotherliquidspossiblycontaining
chlorinewereuncontrolled, sothesestudiesdo notexcludethe
possibility that chlorineaffects human lipid metabolism.
Wones and colleagues conducted a 15-week dose-response
trialofdrinking waterchlorine(0, 2, 5, 10ppm) in 19healthy men
and observed a clinically small increase (3%) in total plasma
cholesterol levelsatchlorineconcentrations of5 ppmand 10ppm
(6). However, no control group was studied, and it is possible
thattheobservedincrease wasdue totheprotocoldiet orother
factors and not to the chlorine.
Zeighami andcolleagues reported an epidemiological study
of40 small Wisconsin communities, 20 of whom chlorinated
theirwatersupplyand20ofwhomdidnotchlorinatetheirwater
supply (7).W,menlivingincommunitieswithchlorinated water
suppliesappearedtohaveslightlyhighertotalcholesterol levels
(about 5%) than women living in communities with unchlori-
natedsupplies. Therewasnosignificantdifferencefoundinmen.
Whilethesefindingsareintriguing, they suggestonly anassocia-
tionbetweenchlorine indrinking waterand serumcholesterol
levels in women. Prospective experimental data are needed to
determine whether this association is causal or coincidental.WONESETAL.
Thus,publishedreportsinhumansareinsufficienttoeithercon-
firmorexcludeaneffectofdrinkingwaterchlorineonhumanlipid
orthyroidmetabolism. Thepurposeofthisstudywastodetermine
ifdrinking water containing 20 ppm chlorine affected lipid or
thyroid metabolism in healthy women unselected for baseline
total cholesterol levelsorinhealthy menselectedtohavebaseline
total cholesterol levels above the 50th percentile for their age.
Methods
This study was a randomized, controlled, parallel trial of 8
weeks' duration. The smell and tasteofchlorine at 20 ppm ob-
viated blinding ofthe subjects or investigators. The study pro-
tocol is illustrated inFigure 1. Theprotocol consistedofa4-week
dietary stabilization period during which all subjects drank
distilled waterbuffered with sodium monophosphatetoapHof
8.0. Thepurposes ofthebaselineperiod weretoachievestabiliza-
tion on a high-fat, high-cholesterol dietand toallow the effects
ofpriorexposure tochlorinated watertodissipate. Thebaseline
period was followed by a4-weektreatment periodduringwhich
halfofthe subjects was assigned randomly tocontinue consum-
ingbuffereddistilled water(distilled group), whiletheotherhalf
wasassignedtoconsume 1.5 Lperdayofdrinkingwatercontain-
ing 20 ppm (ppm = mg/L) chlorine buffered with sodium
monophosphate to a pH of8.0 (chlorine group). The trial was
conducted inthe General Clinical Research Center (GCRC) at
the University ofCincinnati Hospital andwasapprovedby itsIn-
stitutional Review Board; all subjects gave written informed con-
sent to participate.
This study used achlorineconcentration 10times higherthan
that routinely found in public water supplies because previous
work by ourgroup foundnoeffect at2ppmandonlyapossible,
small effect at5 ppmor 10ppm(6). Becauseoftheresultsofthe
epidemiological study cited above (7), and because the effects
of chlorine on lipid metabolism in females had not been ex-
perimentally determined previously, we first studied healthy
women unselected for baseline cholesterol levels. Because the
impact of drinking water chlorine on lipid metabolism was
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clinically unimpressive inourprevious studyofunselectedmen
(6), we nextchoseto study men withbaselinecholesterol levels
abovethe50thpercentiletodeterminewhetherelevatedbaseline
cholesterolmightbeassociated withanincreasedresponsiveness
to chlorinated drinking water.
Inclusion criteria for the women's group included: healthy
females between the ages of 18-65 years; no medications (in-
cluding birthcontrol pills); and no concurrent illnesses. Inclu-
sion criteria for the men'sgroup were identical tothe women's
exceptthat screening cholesterol levels formales were required
to be greater than the 50th percentile but less than the 90th
percentile fortheir age (8).
The study diet was designed individually to satisfy the food
preferences ofeach subjectand tobe isocaloric. Each subject's
dietplanwasadjustedasnecessarybyaGCRCdietitiantomain-
tainthesubjectathisorherinitial weight. Thedietconsistedof
20% protein, 40% carbohydrate, and40% fat. Itcontained600
mgofcholesterol/day andapolyunsaturated tosaturatedfatratio
of0.4. Dietary calcium was restricted to 80% ofthe minimum
daily requirement for American- adults.
Thecharacteristics ofthe study dietsweredesignedtomimic
Revis' study in pigeons (4). Therefore, the study diets were
relatively highintotal fat, saturatedfat, andcholesterol. Despite
the high fat and cholesterol content, such diets are not unusual
formanyAmericans. OnlyoverthelastdecadehaveAmericans
consumed less fatand cholesterol onaverage (9). The calcium
restrictionalso reflects nutritional patterns inthiscountry since
manypeople, especially womenandolderAmericans, consume
adietcontaining 80% orless ofthe recommended daily allow-
anceofcalcium (10). Study diets wereformulatedtoavoid foods
that contain chlorine (i.e., bleached flour). In summary, the
study diets were designed to maximize the potential for obser-
vingasmalleffectofchlorineon lipidandthyroidmetabolism,
minimizetheinfluence ofextraneousdietary confounders, and
preserve generalizability.
All food wasprepared inthe GCRC kitchen. Twodaily meal
plans wereused foreachsubjectsothateachpersonatethe same
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DRINKING WATER: Distilled = 1.5 liter perday distilled water buffered to pH 8.0with NaHPO4
Chlorine = 1.5 liter perday 20 ppm chlorinated distilled water buffered to pH 8.0with NaHPO4
DIET: Isocaloric; 20% protein, 40%fat, 40%carbohydrate; 600 mg cholesterol perday; P:S ratio 0.4.
LABORATORY: * Total Cholesterol, TriglycerIdes, HDL-C, LDL-C (calculated), T4,T3, T3 resin uptake, TSH,
apolipoproteins Al, A2, and B.
R: RandomizatIon
FIGURE 1. Study protocol.
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meals every otherday for56days. Subjects were requiredtoeat
at least two meals and drinkno lessthan 1.5 Lofdrinking water
each day. These meals and the mandatory drinking water were
consumed in the GCRC under observation. A third meal and a
snack were packed for those subjects who wanted to consume
them at home or at work. Subjects were instructed not to eat or
drink anything which had not been provided for them.
Other lifestyle factors which might affect lipidorthyroid levels
were controlled as well as possible. Subjects were instructed not
to drink alcohol. Ifthey smoked cigarettes, they were asked to
keep their smoking constant throughout the study. They kept
diaries ofexercise activities and were asked to keep their exer-
cise habits constant. Subjects were required to refrain from
swimming during the study to avoid exposure to chlorine from
pool water.
Drinkingwater foreach subject wasprepared by standardpro-
cedures. Water was distilled and passed through an activated
charcoal filter to remove any trace organic impurities. Before
launching the study, samples ofthe resulting purified water were
submitted tothe Environmental Protection Agency (EPA) Health
Effects Research Laboratory inCincinnati and werejudged tobe
free oftrace organic impurities. A highly concentrated solution
of chlorine (250 ppm) was prepared by bubbling chlorine gas
through water alkalinized to pH 8.0 with sodium hydroxide. A
concentrated sodium monophosphate buffer solution at pH 8.0
was prepared in the GCRC Core Laboratory. Each day, GCRC
dietary staffmixedaliquots ofthese concentrated solutions with
distilled water topreparethatday's drinking waterforeach sub-
ject. The final pH and chlorine concentration ofone subject's
drinking waterwas checked each day to assure that subjects ac-
tually received theappropriate concentration ofchlorine. Each
subject's drinking water was prepared and stored in a well-
marked thermos. Studies of these thermos containers docu-
mented thatthe chlorine concentration was stablefor at least 24
hr and that loss ofchlorine due to evaporation did not occur.
Subjects werealsoprovided with athermos ofdistilled water
freeofchlorine and bufferwhich they could drinkattheiroption
in addition to the 1.5 L ofstudy water which they had to drink.
Consumptionofmandatory andoptional waterwasmonitored by
daily checks ofsubjects' thermoses. Twenty-four-hour fluid in-
takes were recorded daily.
All subjects reported in the fasting state each morning to the
GCRC for measurement ofweight, blood pressure, pulse rate,
and temperature by aGCRC staffnurse. Blood wasdrawn week-
ly fortotal cholesterol, triglycerides, HDLcholesterol (HDL-C),
apolipoproteins Al, A2 and B, thyroxine (T4), triiodothyronine
(T3), T3 resinuptake, andthyroid-stimulating hormone (TSH).
During weeks 4 and 8, blood samples were obtained on 4 con-
secutive days. On day 0, 28, and 56, safety tests (serum elec-
trolytes, blood ureanitrogen and creatinine, glucose, livertran-
saminases and alkaline phosphatase, calcium andphosphorous,
urinalysis, white and red blood cell counts, reticulocyte count,
and methemoglobin) were performed. A single measurement of
glucose 6-phosphate dehydrogenase (G6PD) was made at entry
to detect individuals who might be susceptible to hemolytic
anemia due to the oxidizing effects ofchlorine.
All blood samples were drawn from the antecubital veins of
supine subjects. Lipid, lipoprotein, and apolipoprotein analyses
were collected in sodium/potassium ethylenediaminotetracetate
(EDTA, 1 mg/mL) anticoagulated tubes, and the plasma was
separatedquickly fromthecells by centrifugation. The plasma
sampleswerefrozenat -20°Candanalyzedasabatch foreach
subject. Total cholesterol, triglycerides, and HDL cholesterol
were measuredbymicroenzymatic procedures, standardizedand
monitored through theCenterforDisease Control's Lipid Stan-
dardizationProgram(11). HDLwasisolatedusingthemodified
heparin-manganese chloride procedure (12). Interference in the
enzymatic procedure waseliminated by theadditionof8mEq/L
ofEDTA to thecholesterol reagent (13). Apolipoproteins (Apo)
Al and B werequantitatedby electroimmunoassay (14)and Apo
A2 by enzyme-linked immunoabsorbent assay (15). LDL
cholesterol (LDL-C) was calculated as total cholesterol minus
HDL-C minus triglycerides divided by 5. The other tests listed
above were performed bythe clinical laboratories oftheUniver-
sity ofCincinnati Hospital using standard procedures which are
available upon request.
Results ofthe lipid andthyroid function tests were analyzed as
follows. For each subject, the mean ofthe four consecutive dai-
ly measurements during week 4wasconsidered asthe "baseline"
valueand themean ofthefourdaily measurementsduring week
8, the "treatment" value. The treatment value minusthebaseline
value was the "change" value for each person. The primary
analysis compared themean ofthechange values forthedistilled
groups to the mean ofthe change values for the chlorine group
using atwo-sample t-test. A secondary analysis using the lipid,
lipoprotein, and thyroid data from all 8 weeks was performed
also using repeated measures analysis ofvariance. Allp-values
were two-tailed. Sample size determinations made before the
study using variance data from aprevious study (6), an alpha of
0.05, andabetaof0.20 indicated that 11 subjects wouldbe needed
in each group to observe a change in total cholesterol ofS %.
Results
Thirty-onewomen entered and thirty completed the study pro-
tocol. Onewoman was dropped from the study onday 23 due to
noncompliance with diet. Entry data for the women in the con-
trol andthechlorine groups arepresented in Table 1. No signifi-
cant differences in age, weight, or total cholesterol existed be-
tween the groups. Fourteen women inthedistilled group and 12
in the chlorine group were premenopausal.
Baseline, treatment, andchange lipidand thyroidfunction test
results forthewomen in the chlorine and distilled water groups
are shown in Table 2. There were no differences between the
groups for these parameters at baseline (two-sample t-tests).
There were no differences between the chlorine and distilled
groups for changes between weeks 4 and 8 in any ofthe lipid or
thyroid parameters. Similarly, the analysis using the data from
all weeks showed noeffectofchlorine onanyoftheseparameters.
No abnormalities in any of the safety tests occurred in either
group. Using the variance data from this trial and assuming an
alpha of 0.05, this study had a 73% chance of detecting a 5%
change (9.5 mg/dL) in total cholesterol.
Thirty-two men began and 31 completed the protocol, and
usable data were available for 30. One subject was eliminated
from the study onday 6 due to a seizure. This subject had a dis-
tant history ofa seizure disorder, but he was on no anticonvul-
santmedications atthe timeofentry andhis seizuredisorder was
thought to be inactive. One subject in the chlorine group com-
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Table 1. Entrydata forsubjects.
Wonen Men
Distilled Chlorine Distilled Chlorine
Number ofsubjects 15 15 15 15
Meanage, years' 33.8 ± 9.2 35.6 ± 10.0 34.1 ± 11.3 26.7 ± 4.5*
Age range, years 23-56 21-56 23-55 21-34
Weight, kga 68.3 ± 18.5 66.7 ± 18.4 76.0 ± 7.5 73.7 ± 10.5
Weight range, kg 47-111 44-103 68-95 50-93
Entry cholesterol, mg/dLa 173.3 ± 28.7 183.1 ± 37.4 212 ± 34.0 209.4 ± 27.1
Entry cholesterolrange, mg/dL 123-227 135-264 157-274 178-258
Race
Caucasian 9 7 7 11
Black 5 7 8 3
Oriental 1 1 0 1
Previous source ofdrinking water
Tap 15 15 13 13
Bottled 0 0 1 2
Well 0 0 1 0
'Mean ± SD.
*p = 0.03.
Tble2. Effectsof20 ppmchlorineonlipidandthyroid parametersin women.2
Parameter Numberofsubjects Group Baseline Treatment Changeb p-Value'
Total cholesterol, mg/dL 15 Distilled 182.3 ± 6.68 182.8 ± 7.23 -4.00
0.87
15 Chlorine 196.3 ± 11.03 195.0 ± 11.39 -1.30
Total triglycerides, mg/dL 15 Distilled 57.5 ± 7.06 57.8 ± 6.62 +0.30
0.74
15 Chlorine 67.6 ± 10.92 66.9 ± 10.48 -0.70
HDLcholesterol, mg/dL 15 Distilled 57.5 ± 3.47 58.2 ± 3.33 +0.70
0.68
15 Chlorine 59.9 ± 2.98 61.1 ± 3.30 +1.30
LDLcholesterol, mg/dL 15 Distilled 114.3 ± 6.71 113.1 ± 7.65 -1.20
0.78
15 Chlorine 122.9 ± 10.18 120.5 ± 9.83 -2.40
LDL/HDL ratio 15 Distilled 2.11 ± 0.20 2.08 ± 0.21 -0.03
0.52
15 Chlorine 2.17 ± 0.24 2.08 ± 0.22 -0.09
Apolipoprotein Al, mg/dL 15 Distilled 136.2 ± 4.00 136.4 ± 4.38 +0.20
0.88
15 Chlorine 135.4 ± 3.30 137.0 ± 3.50 +1.60
Apolipoprotein A2, mg/dL 15 Distilled 39.4 ± 1.14 40.2 ± 1.40 +0.80
0.20
15 Chlorine 45.9 ± 2.10 44.5 ± 2.04 -1.40
ApolipoproteinB, mg/dL 15 Distilled 101.8 ± 5.62 106.8 ± 7.00 +5.00
0.75
15 Chlorine 108.8 ± 7.52 111.9 ± 7.29 +3.10
T4, jig/dL 15 Distilled 6.99 ± 0.41 7.22 ± 0.33 +0.23
0.56
15 Chlorine 7.82 ± 0.29 7.90 ± 0.37 +0.08
T3, gg/dL 15 Distilled 117.3 ± 5.79 116.5 ± 4.28 -0.80
0.92
15 Chlorine 125.0 ± 3.88 123.7 ± 4.43 -1.30
T3 Resin uptake, % 15 Distilled 93.9 ± 2.80 93.5 ± 1.95 -0.40
0.52
15 Chlorine 92.0 ± 2.20 92.5 ± 2.03 +0.50
Thyroid-stimulating hormone, AU/mL 15 Distilled 2.93 ± 0.28 3.10 ± 0.29 +0.17
0.20
15 Chlorine 2.65 ± 0.13 2.63 ± 0.13 -0.02
aMean ± SEM for eachparameter.
bChange = treatment (week8) - baseline (week4).
cp [Change (distilled) = change(chlorine)] is lessthanthevalue shown.
pletedtheprotocolbuthisdatawerenotincludedintheanalyses
becausehedevelopedaviralgastrointestinal illnessduring the
fourth week of the study that led to a major decrease in his
cholesterol values so thathis baseline period results were not
representative of his usual state. Entry data for the men are
presented in Table 1. The mean age ofthe chlorine group was
slightly lowerthanthatofthedistilledgroup, buttherewereno
differences inweightortotal cholesterol atentry.
Baseline,treatment, andchangelipidandthyroidfunctiontest
resultsforthemeninthechlorineanddistilledwatergroupsare
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lkble3. Effectsof20 ppmchlorineon lipid andthyroid parameters in men.'
Parameter Numberofsubjects Group Baseline Treatment Changeb p-valuec
Total cholesterol, mg/dL 15 Distilled 215.5 ± 8.11 222.4 ± 7.09 +6.90
0.12
15 Chlorine 201.7 ± 7.88 202.8 ± 9.10 +1.10
Total triglycerides, mg/dL 15 Distilled 76.2 ± 7.21 81.8 ± 8.24 +5.60
0.35
15 Chlorine 78.1 ± 5.67 79.8 ± 7.21 +1.70
HDL cholesterol, mg/dL 15 Distilled 48.9 ± 3.75 49.1 ± 3.88 +0.20
0.64
15 Chlorine 49.6 ± 2.97 49.4 ± 2.93 -0.20
LDL cholesterol, mg/dL 15 Distilled 151.4 ± 7.10 156.9 ± 6.30 +5.50
0.15
15 Chlorine 136.5 ± 6.85 137.5 ± 8.29 +1.00
LDL/HDL ratio 15 Distilled 3.34 ± 0.26 3.48 ± 0.29 +0.14
0.20
15 Chlorine 2.86 ± 0.18 2.89 0.21 +0.03
ApolipoproteinAl, mg/dL 15 Distilled 128.0 ± 4.56 132.8 ± 4.23 +4.80
0.29
15 Chlorine 130.0 ± 4.48 131.2 ± 4.06 +1.20
Apolipoprotein A2, mg/dL 15 Distilled 44.6 ± 2.35 45.0 ± 2.07 +0.40
0.65
15 Chlorine 44.9 ± 1.16 44.9 ± 1.60 0.00
Apolipoprotein B, mg/dL 15 Distilled 129.6 ± 6.19 136.5 ± 5.69 +6.90
0.39
15 Chlorine 118.4 ± 5.18 117.3 ± 5.86 -1.10
T4, ug/dL 15 Distilled 7.94 ± 0.26 8.15 ± 0.27 +0.21
0.05
15 Chlorine 7.97 ± 0.47 7.86 ± 0.41 -0.11
T3, jg/dL 15 Distilled 136.6 ± 5.25 138.8 ± 4.79 +2.20
0.04
15 Chlorine 138.1 ± 8.29 133.1 ± 8.53 -5.00
T3 Resin uptake, % 15 Distilled 93.3 ± 2.41 92.6 ± 2.50 -0.70
0.61
15 Chlorine 99.1 ± 2.67 99.0 ± 2.56 -0.10
Thyroid-stimulating hormone, jAU/mL 15 Distilled 2.38 ± 0.20 2.36 ± 0.16 -0.02
0.38
15 Chlorine 2.34 ± 0.19 2.44 ± 0.25 +0.10
aMean ± SEM foreachparameter.
bChange = treatment (week8) - baseline(week4).
cp [Change (distilled) = change (chlorine)] is less than the value shown.
showninTable3. Nosignificantdifferencesbetweenthegroups
at baseline were evident (two-sample t-tests). There were no
clearly significantdifferencesbetweenthegroupseitherby com-
paring treatment (week 8) to baseline (week 4) orby repeated
measures ANOVA using the weekly data. The small decreases
inthyroxineandtriiodothyronine inthechlorinegrouprelative
to the distilled water group werejudged not to be meaningful
because of borderline statistical significance and because
thyroid-stimulating hormonelevelsdidnotchange. Meaningful
changes in thyroxine and triiodothyronine should be accom-
panied by changes in thyroid-stimulating hormone levels. The
absence ofsuchchangessuggestthatnophysiologic impacton
thyroid metabolic statusoccurred asaresultofchlorineinges-
tion. Noadversechanges inanyofthesafety tests were seenin
eithergroup. Usingthevariancedatafromthistrialandassum-
ing an a of0.05, this studyhada79% chanceofdetecting a5%
change in total cholesterol.
The data for both the men and the women were examined
qualitatively to determine whether any identifiable subgroup
might have been affected by the drinking water chlorine even
thoughtheoverallanalysesshowednoeffect. Formalstatistical
analysesofsubgroupswerenotpossibleduetothesmallnumbers
ofsubjectsineachsubgroup. Nosubgroupsbasedonage, race,
baselinetotalcholesterol, orsourceofprestudydrinking water
appeared tobeuniquely affectedby thechlorine.
Thedrinking waterwaswelltoleratedby thesubjects. Three
womenexperiencedloosestoolsatthebeginningofthe4-week
chlorine treatment period that resolved by the seventh day of
treatnent. Onewomanexperiencedintermittentloosestoolsdur-
ing both the 4-week baseline period and the 4-week chlorine
treatnentperiod. Thissubjectweighed45kgandtheloosestools
may have been related to the ingestion ofa larger-than-usual
volumeofwater. Tlwomeninthedistilledgroupandtwomenin
thechlorinegroupreportedgastrointestinalcomplaintswhileon
the protocol. In the distilled group, one subject had a single
episodeofdiarrheaduring the fifth week, whiletheother sub-
jecthadintermittentdiarrheaandmildabdominalcrampsdur-
ingthelast4weeksofthestudy. Inthechlorinegroup, onesub-
jecthadoneepisodeofconstipationduringthe8weeksandone
subjecthad3daysofloosestoolsatthebeginningofthechlorine
treatment period that resolved by the fifth week. Two women
subjectswhoreceivedchlorinewerefoundtobeG6PDdeficient
at entry into the study, but they experienced no detectable
hemolysis whiledrinkingchlorinatedwater.
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Discussion
The short-term (4 weeks) consumption ofchlorinated drink-
ing water (20ppm) doesnotaffectcirculating parametersoflipid
orthyroid metabolism inhealthy womenunselected forbaseline
total cholesterol levels or in healthy men with baseline total
cholesterol levels abovethe median fortheirage. Thesedata in
humans are contrary to results from investigations in animals
showing an increase in serumcholesterolafteradministration of
variousdosesofchlorinated drinking water (0.1-30ppm) (2,4).
Ourfindingssupportpreviousuncontrolled resultsinhumansby
Lubbers andcolleagues (5) who found no significant effect on
serumcholesterol fromeitherasingle-doseexposuretochlori-
nated water(0.1 ppmto24ppm) orfroma 12-weekexposureto
0.5 L/day of5 ppm chlorinated water.
The resultsofthesestudies suggestthatthe3% increase intotal
cholesterol we observed in a previous, uncontrolled study (6)
was not dueto the ingestion ofdrinking waterchlorine but was
more likely due to the protocol diet. The men in the distilled
group in the study reported here experienced a 3% increase in
total cholesterol betweenthe end ofthebaseline and the end of
thetreatmentperiodsdespitethefactthattheydidnotreceiveany
chlorine. Indeed, the menwhoconsumedchlorineexperienced
a smaller increase in total cholesterol between the end ofthe
baseline and the end ofthe treatment period (not statistically
significant).
Our resultsalso fail toconfirm thepossibleassociation found
by Zeighamietal. (7)betweendrinkingwaterchlorineandblood
cholesterol in women. These conflicting results could be
explained inone ofseveral ways. It may be that drinking water
chlorinehas noeffectonhumanlipidlevelsandtheassociation
found in theepidemiological study reflects otherunknown fac-
tors that are related to both drinking water characteristics and
blood cholesterol levels. Alternatively, it may be thatdrinking
waterchlorinedoescauseanincrease inbloodcholesterol levels
but that we missed such an effect in this experimental study
becausetheperiodofexposure wastoobrief, oursubjects were
too healthy or too young, or too few subjects were studied to
detect a very small change.
One unanticipated result was afall intotal cholesterol fromen-
try to baseline in the men's chlorine group. We expected total
cholesterol levels to increase from entry tobaselinebecause we
were feeding subjects high-fat and high-cholesterol diets. This
occurred as expected in both women'sgroups and in the men's
distilled group. Theunexpected fall betweenentryandbaseline
in the men's chlorine group could have been achance result or
couldhavebeenrelated totheprestudydietsofthesubjects. This
finding, while interesting, does not invalidate ourconclusions
becausetheprincipalendpointwasthechangebetweenbaseline
andtreatment, notbetweenentry andtreatment. Indeed, had we
comparedentry totreatment, itwouldappearthatchlorinehad
a cholesterol-lowering effect in men.
Theprincipal limitationsofthisstudy weretherelatively brief
baselineandtreatmentperiodsandthegoodhealthofthesubjects
studied. Almost all subjects consumed chlorinated drinking
water from local water supplies before entry into the protocol.
The 4-week baseline period may not have been longenough to
achieve adequate washout ofthe effects ofpreviously ingested
chlorine. Alternatively, the 4-week treatment period may have
been too brief to see an effect. The length ofthe baseline and
study periods werechosenbased ontheclinical observation that
mostfactorsthataffectbloodcholesterol levels, including diet,
do so within a time span of4 weeks (16). Also, practical con-
siderations involved withstudying humans limitedthemaximum
possible lengthofexposure. Theotherpossiblelimitation ofthis
study wasthatthesubjects, bydesign, werehealthy. Indeed, the
averagebaselinetotalcholesterol level inwomen inthestudy was
below200mg/dL. Themenwereselectedtohavehigherbaseline
levelsbuttheyalso wereuniformly healthy exceptformildly in-
creasedcholesterol levels. Itmay bethatpeople who are not as
healthy overall asoursubjects wouldbemoreaffectedbydrink-
ing chlorinated water.
In summary, this randomized, controlled trial failed to show
anymeaningful effectofdrinking waterchlorineataconcentra-
tionof20ppm on parameters oflipidorthyroid metabolism in
healthy menandwomen. Whiletheresultsofanimal studiesand
anepidemiological surveyareinterestingandmeritfurtherstudy,
the consistent lack of prospective, experimental evidence in
humanslinkingdrinking waterchlorinetochanges inparameters
of lipid and thyroid metabolism argues that major changes in
waterdisinfection practices in responsetoconcernsabouthyper-
cholesterolemia are not warranted atthis time.
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